PBT fell 29.6% as costs outpaced 4.1% revenue growth

Operating profit fell 31.2% to NZ$42.1m, PBT fell 29.6% to NZ$39.8m, and NPAT fell 28.5% to NZ$28.3m. The effective tax rate barely shifted (29.0% versus 30.0%), so the earnings decline is operating in nature, not tax-driven.

Cash performance moved in the opposite direction. Operating cash flow rose 46.3% to NZ$74.9m, capex fell to NZ$18.5m (5.0% of revenue, down from 5.6%), and pre-lease free cash flow reached NZ$56.4m versus NZ$31.3m. Gross borrowings were cut from NZ$102.1m to NZ$3.4m, leaving Sky in a net cash position of roughly NZ$70.5m. No interim dividend was declared, with management signalling resumption from FY22.

HY21 carried a 30% EBITDA lift and a 234% NPAT recovery, so part of the decline is normalisation against a peak. Even allowing for that, the 4.1% revenue rise translating into a 31.2% operating profit decline points to cost reinflation – likely a mix of programming, content, and growth investment – that the release does not quantify. This matters because it reframes the "return to revenue growth" headline as growth that is currently destroying operating profit.

Cash generation and balance sheet repair are the genuine bright spot. Pre-lease FCF of NZ$56.4m sits at the upper edge of Annolyse's historical baseline (4-period mean NZ$29.3m, range NZ$6.8m–NZ$87.1m), and FCF-to-NPAT conversion of 199.4% is unusually high. Coupled with the near-elimination of gross debt, Sky exits HY22 with materially more financial flexibility than a year ago.

ROE has weakened to 6.2% from 9.6% even as equity grew 11.2% to NZ$456.6m. The denominator is helping equity, but lower earnings are dominating, so capital is being preserved rather than compounded at the prior rate.

The supplied seasonality shape is unhelpful as a guide: HY21 represented 83.8% of FY21 NPAT and 62.4% of FY21 EBITDA, so the historical pattern is first-half-weighted and an HY22 NPAT of NZ$28.3m does not annualise cleanly. Annualising HY22 revenue gives roughly NZ$743m, modestly above FY21's NZ$711m, which is consistent with the "return to growth" framing.

The dividend resumption signalled for FY22 is the more important forward indicator. With FCF pre-lease at NZ$56.4m, near-zero debt, and a 0.0% payout, capacity to restart distributions is comfortably in place; what the release does not pin down is timing, quantum, or whether capital will instead be redirected to the "investment opportunities" referenced in commentary.

OCF growth of 46.3% on revenue growth of only 4.1% was substantially helped by a NZ$51.1m operating working-capital release, which is within Annolyse's historical baseline (4-period mean NZ$-263.3m) but is still a one-off contributor to cash this half. Stripping that out, underlying cash generation is closer to the prior comparable than the headline suggests, and the upper-edge FCF reading should be treated as partly working-capital-assisted rather than fully durable.

The earnings result is lower quality than the cash result implies. Revenue growth that does not convert into operating profit growth means margin compression, and without an EBITDA disclosure for HY22 the magnitude of underlying operating leverage loss cannot be sized from this release. Debtor days of 26.4 are flagged above Annolyse's baseline (mean 3.4 days), though they moved only marginally from the prior comparable of 27.6 days, so the elevation looks structural to this period rather than a new deterioration.

This briefing cannot assess the underlying cost mix, subscriber dynamics, or content commitments behind the operating margin compression, because the supplied release does not disclose them.